High Dose Intravenous Vitamin C reduces tumors by 50%
Patient: Go Home and Die, Doctors told lung cancer patient.
Dr. Scott Greenburg. Study being done at Thomas Jefferson in Philadelphia
Video: Patient told to “Go Home and Die”
IV vitamin C doubles survival time of pancreatic cancer patients in new clinical trial
Pharmacokinetic Model of Intravenous Vitamin C
This spreadsheet was created by Dr. Joseph Casciari, a dear friend and genius collaborator. It allows for the prediction of plasma levels of ascorbate. Input dose, duration, volume, patient height and weight.Vitamin C Pharmacokinetic Curves
The Potential Role of Ascorbic Acid and its Salts in the Management of Malignant Diseases
Ph.D. Dissertation NHRDissertationFinal
First Blog
This website is dedicated to the science of the effects of vitamin C on malignancies and people with malignant diseases.
My father, Hugh Riordan, had a patient in the early 1980’s come to his clinic requesting intravenous vitamin C. The patient, a 70-year-old man (I’ll refer to him as “Sam”) was recently diagnosed with renal (kidney) cell carcinoma. The cancer had spread to his lungs. His oncologist had told him there were no treatments available to him. Sam had read about the work of Linus Pauling and Ewen Cameron–Link: Prolongation survival Pauling. In the so-called Vale of Leven trial, 100 terminal cancer patients were given 10 grams of vitamin C per day. The people receiving the vitamin C lived an average of 300 days longer than 1000 matched controls (people receiving the same treatment without the vitamin C). 22% of the treated patients were alive 1 year after being deemed “untreatable” versus 0.4% of the controls.
Dr. Hugh, as my father was known, was known to be the only doctor in Wichita, Kansas who gave vitamin C through the vein (intravenously). Sam was given 30 grams of vitamin C intravenously (IVC) twice per week. A copy of the journal article can be found here. 5 months later no evidence of cancer could be found. This paper was written 3.5 years after he started the IVC treatments and at that time no evidence of cancer could be found. A subsequent paper about another patient referred to Sam and stated he died cancer free of congestive heart failure 12 years after starting treatment.